Tiziana Life Sciences
TLSA
23 hedge funds and large institutions have $3.17M invested in Tiziana Life Sciences in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.
0.04% less ownership
Funds ownership: 5.21% → 5.16% (-0.04%)
8% less funds holding
Funds holding: 25 → 23 (-2)
24% less capital invested
Capital invested by funds: $4.15M → $3.17M (-$980K)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$26K |
| 2 |
State Street
Boston,
Massachusetts
|
+$17.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.57K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$505 |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$308 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$25.5K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$17K |
| 3 |
Citigroup
New York
|
-$14.3K |
| 4 |
VF
Virtu Financial
New York
|
-$12K |
| 5 |
Jane Street
New York
|
-$8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Simplex Trading
Chicago,
Illinois
| – | +$308 | +465 | New |
|
TLSA Hedge Fund Activity: Q4 2022 in Review
23 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q4 2022, worth a combined $3.17M — down 24% from $4.15M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of TLSA and 3 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 3 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $26K. The largest seller was Morgan Stanley, cutting an estimated $25.5K.
- 23 institutional investors held Tiziana Life Sciences (TLSA) as of Q4 2022, down from 25 in Q3 2022.
- Funds reported $3.17M of Tiziana Life Sciences stock for Q4 2022, down 24% quarter-over-quarter.
- 3 funds opened new Tiziana Life Sciences positions in Q4 2022 and 5 closed out, a net change of -2 holders.
- The largest Tiziana Life Sciences buyer in Q4 2022 was Susquehanna International Group, an estimated $26K added.
- The largest Tiziana Life Sciences seller in Q4 2022 was Morgan Stanley, an estimated $25.5K sold.
Based on aggregated 13F filings for Q4 2022.